Workflow
【美股盘前】三大期指齐跌,钢铁和铝业股普涨;FDA批准新型新冠疫苗,莫德纳涨超4%;谷歌表示将对在线搜索反垄断裁决提出上诉;Blueprint Medicines涨逾27%,赛诺菲将以91亿美元发起收购;特斯拉5月在瑞典销量同比下降53.7%
Mei Ri Jing Ji Xin Wen·2025-06-02 09:39

Group 1 - U.S. stock index futures are down, with Dow futures down 0.43%, S&P 500 futures down 0.50%, and Nasdaq futures down 0.67% [1] - U.S. steel and aluminum stocks are rising ahead of market opening, following Trump's announcement to increase import tariffs on steel from 25% to 50%. Cleveland-Cliffs Inc. is up 25.56%, Nucor Corporation is up 8.69%, and Steel Dynamics Inc. is up 9.69% [1] - Moderna's new low-dose COVID-19 vaccine has been approved by the FDA, leading to a 4.74% increase in its stock price [1] Group 2 - Google plans to appeal a recent antitrust ruling that found it guilty of illegal monopoly in the advertising technology sector, resulting in a 0.9% drop in its stock [2] - Novartis reports strong results from clinical trials of its cancer drug Pluvicto for advanced prostate cancer patients [2] - Sanofi is set to acquire Blueprint Medicines for $9.1 billion, with Blueprint's stock rising 27.08% following the announcement [2] Group 3 - Apple has appealed against the EU's Digital Markets Act, which requires it to share user data with third-party developers, causing its stock to drop 0.76% [3] - Tesla's new car sales in Sweden fell by 53.7% year-over-year in May, with only 503 vehicles sold, leading to a 2.17% decline in its stock [3]